Finance

Lists
Outlook: 79.0% bullish·0.0% bearish
Go to analysis
HAE:NYSE
Haemonetics Corp
၁၂၁.၁၁ US$
-၀.၅၃%
(-၀.၆၄) 1D
အောက် ၁၄, GMT-၄ ၁၆:၀၀:၀၄  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HAE...
Open
၁၂၁.၈၁ US$
High
၁၂၂.၅၃ US$
Low
၁၁၉.၅၅ US$
Mkt. cap
၅၅၁.၀၁ ဋေ
Avg. vol.
၆.၈၈ သိန်း
Volume
၅.၈၀ သိန်း
P/E ratio
၅၉.၀၇
52-wk high
၁၂၃.၇၇ US$
52-wk low
၄၈.၅၅ US$
EPS
၂.၀၅ US$
Beta
၀.၆၁
Shares outstanding
၄.၅၅ ကုဋေ
No. of employees
၃ ထောင်
Open
၁၂၁.၈၁ US$
High
၁၂၂.၅၃ US$
Low
၁၁၉.၅၅ US$
Mkt. cap
၅၅၁.၀၁ ဋေ
Avg. vol.
၆.၈၈ သိန်း
Volume
၅.၈၀ သိန်း
P/E ratio
၅၉.၀၇
52-wk high
၁၂၃.၇၇ US$
52-wk low
၄၈.၅၅ US$
EPS
၂.၀၅ US$
Beta
၀.၆၁
Shares outstanding
၄.၅၅ ကုဋေ
No. of employees
၃ ထောင်
News stories
From web sources and news partners
Zacks
Zacks
·
ပြီးခဲ့သည့် ၁ ရက်
Why Haemonetics (HAE) is a Top Momentum Stock for the Long-Term
Profile
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen Latham in the 1970s. Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas. Wikipedia
About Haemonetics Corp
CEOChristopher Simon
Employees၃.၀၁ ထောင်
Founded၁၉၇၁
Headquartersဘော့စတွန်မြို့, မက်ဆာချူးဆက်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 9 analysts giving stock ratings to HAE in the past 3 months
Strong buy
Buy
7
Hold
2
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for HAE in the last 3 months.
Highest
Current ၁၂၁.၁၁ US$
၁၄၀.၀၀ US$ (+၁၅.၆၀%)
Average
၁၂၅.၃၈ US$ (+၃.၅၃%)
Lowest
၈၆.၀၀ US$ (-၂၈.၉၉%)
Analyst
Recommendation
Action
Price target
Projected
Date
Anthony Petrone
Mizuho Securities
Buy
Maintained
၁၄၀.၀၀ US$
+၁၅.၆%
10/09/2026
Michael Petusky
Barrington
Buy
Maintained
၁၄၀.၀၀ US$
+၁၅.၆%
10/09/2026
Travis Steed
Bank of America Securities
Buy
Reiterated
၁၄၀.၀၀ US$
+၁၅.၆%
10/08/2026
Marie Thibault
BTIG
Buy
Reiterated
၁၃၀.၀၀ US$
+၇.၃%
10/08/2026
Joanne Wuensch
Citi
Buy
Upgraded
၁၂၃.၀၀ US$
+၁.၆%
09/18/2026
Andrew Cooper
Raymond James
Buy
Maintained
၁၂၅.၀၀ US$
+၃.၂%
09/03/2026
David Rescott
Robert W. Baird
Buy
Maintained
၁၁၉.၀၀ US$
-၁.၇%
08/21/2026
Michael Matson
Needham
Hold
Maintained
-
-
08/18/2026
Allen Gong
J.P. Morgan
Hold
Maintained
၈၆.၀၀ US$
-၂၉%
08/10/2026
Rohin K Patel
J.P. Morgan
Hold
Reiterated
၆၂.၀၀ US$
-၄၈.၈%
05/08/2026
Last report
၂၀၂၆ ဩ ၆
Fiscal period
Q1 2027
၁.၁၄ US$ / ၁.၀၈ US$
+၅.၈၅%beat
Revenue / Est. (USD)
၃၃.၉၄ ကုဋေ / ၃၂.၇၉ ကုဋေ
+၃.၅၀%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၃၂.၇၃ ကုဋေ
၃၃.၉၀ ကုဋေ
၃၄.၆၄ ကုဋေ
၃၃.၉၄ ကုဋေ
Cost of goods sold
၁၃.၂၇ ကုဋေ
၁၃.၆၆ ကုဋေ
၁၄.၈၁ ကုဋေ
၁၃.၅၈ ကုဋေ
Cost of revenue
၁၃.၂၇ ကုဋေ
၁၃.၆၆ ကုဋေ
၁၄.၈၁ ကုဋေ
၁၃.၅၈ ကုဋေ
Research and development expenses
၁.၄၅ ကုဋေ
၁.၄၃ ကုဋေ
၁.၄၄ ကုဋေ
၁.၆၂ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁၀.၀၁ ကုဋေ
၁၀.၅၉ ကုဋေ
၁၂.၅၃ ကုဋေ
၁၁.၆၃ ကုဋေ
Operating expense
၁၂.၅၈ ကုဋေ
၁၃.၁၁ ကုဋေ
၁၅.၀၂ ကုဋေ
၁၄.၂၇ ကုဋေ
Total operating expenses
၂၅.၈၅ ကုဋေ
၂၆.၇၈ ကုဋေ
၂၉.၈၃ ကုဋေ
၂၇.၈၅ ကုဋေ
Operating income
၆.၈၈ ကုဋေ
၇.၁၂ ကုဋေ
၄.၈၁ ကုဋေ
၆.၀၉ ကုဋေ
Other non operating income
-၇.၂၁ သန်း
၂.၂၈ သန်း
-၂.၁၂ ကုဋေ
၂.၂၂ သန်း
EBT including unusual items
၅.၁၃ ကုဋေ
၆.၀၀ ကုဋေ
-၂.၈၄ ကုဋေ
၄.၇၆ ကုဋေ
EBT excluding unusual items
၆.၁၆ ကုဋေ
၆.၃၈ ကုဋေ
၃.၇၈ ကုဋေ
၅.၁၀ ကုဋေ
Income tax expense
၁.၂၆ ကုဋေ
၁.၅၂ ကုဋေ
-၈.၂၅ သန်း
၁.၄၆ ကုဋေ
Effective tax rate
၂၄.၅၇%
၂၅.၄၀%
၂၉.၀၆%
၃၀.၆၁%
Other operating expenses
-
-
-
-
Net income
၃.၈၇ ကုဋေ
၄.၄၇ ကုဋေ
-၂.၀၁ ကုဋေ
၃.၃၀ ကုဋေ
Net profit margin
၁၁.၈၂%
၁၃.၂၀%
-၅.၈၂%
၉.၇၃%
Earnings per share
၁.၂၇
၁.၃၁
၁.၂၉
၁.၁၄
Interest and investment income
-
-
၁.၀၁ ကုဋေ
-
Interest expense
-
-၉.၇၀ သန်း
-
-၁.၂၄ ကုဋေ
Net interest expenses
-
-၉.၇၀ သန်း
၁.၀၁ ကုဋေ
-၁.၂၄ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၉.၇၁ ကုဋေ
၉.၈၆ ကုဋေ
၆.၉၃ ကုဋေ
၈.၈၀ ကုဋေ
Gain or loss from assets sale
-၇.၅၀ သောင်း
-၂.၁၈ သိန်း
-၁.၇၈ သိန်း
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ